Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 009190
Company: GUERBET
Company: GUERBET
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LIPIODOL | ETHIODIZED OIL | EQ 4.8GM IODINE/10ML (EQ 480MG IODINE/ML) | OIL;INTRALYMPHATIC, INTRAUTERINE | Prescription | None | Yes | Yes |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/05/2023 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009190s032lbl.pdf | |
06/10/2020 | SUPPL-31 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009190s029s031lbl.pdf | |
06/10/2020 | SUPPL-29 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009190s029s031lbl.pdf | |
04/04/2014 | SUPPL-24 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/009190s024lbl.pdf | |
03/21/2014 | SUPPL-21 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/009190s021lbl.pdf |